NCT03443726

Brief Summary

This study is a Randomized Controlled Trial (RCT) which objective is to compare the effectiveness, efficacy and complication associated to an infiltrative anesthetic technique for the removal of lower third molars comparing it to the standard inferior alveolar nerve block using 4% articaine 1:100.000 epinephrine.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 10, 2017

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

December 20, 2017

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 23, 2018

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 10, 2018

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2018

Completed
Last Updated

March 31, 2020

Status Verified

March 1, 2020

Enrollment Period

1.4 years

First QC Date

December 20, 2017

Last Update Submit

March 30, 2020

Conditions

Keywords

Lower third molar extractionInfiltration anesthesiaArticaine

Outcome Measures

Primary Outcomes (1)

  • Need for supplemental anesthesia [Efficacy]

    Using a questionnaire filled by the surgeon at the end of surgery. Need for supplemental anesthesia (yes/no)

    At the end of surgery (≤60 minutes after pulpal anesthesia is achieved)

Secondary Outcomes (27)

  • Local anesthetic injection pain

    After local anesthetic injection (minute 0)

  • Morbidity

    After local anesthetic injection (minute 0)

  • Latency

    After anesthetic injection (approximately 0 to 360 seconds)

  • Pulpal anesthesia

    Minute 1 (after Vincent's sign is achieved)

  • Pulpal anesthesia

    Minute 1.5 (after Vincent's sign is achieved)

  • +22 more secondary outcomes

Study Arms (2)

Infiltrative technique

EXPERIMENTAL

Patients in this arm will have buccal and lingual infiltrative anesthesia with 4% articaine 1:100.000 epinephrine for third molar extraction.

Procedure: Infiltrative techniqueDrug: 4% articaine 1:100.000 epinephrineProcedure: Third molar extraction

Nerve block technique

ACTIVE COMPARATOR

Patients in this arm will have inferior alveolar nerve and buccal nerve block with 4% articaine 1:100.000 epinephrine for third molar extraction.

Procedure: Nerve block techniqueDrug: 4% articaine 1:100.000 epinephrineProcedure: Third molar extraction

Interventions

Inferior alveolar nerve block with 1.8 cc of 4% articaine 1:100.000 epinephrine and 1.8 cc of the same anesthetic for the buccal nerve for third molar extraction.

Also known as: Standard intervention
Nerve block technique

Infiltrative anesthesia buccally between first and second mandibular molar with 3.6 cc of 4% articaine 1:100.000 epinephrine and 0.6 cc lingually to the third molar using the same anesthetic solution.

Also known as: Experimental intervention
Infiltrative technique

Articaine in a 4% solution with epinephrine 1:100,000 (Artinibsa; Inibsa Dental, Lliçà de Vall, Spain)

Infiltrative techniqueNerve block technique

Third molar extraction under local anesthesia.

Infiltrative techniqueNerve block technique

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Lower third molars in any position (in accordance to Pell and Gregory and Winter classification) in need of extraction.
  • Healthy patients and patients with mild systemic disease without substantive functional limitations (ASA I-II).
  • Absence of acute infection in the third molar area.
  • Adequate intellectual capacity for understanding the nature and purpose of the study and fill the informed consent and questionaries appropriately.

You may not qualify if:

  • History of recent trauma in the maxillofacial area.
  • Articaine or lidocaine allergy.
  • Presence of a systemic pathology that contraindicates the use of local anesthetics with vasopressors.
  • Acute infection in the third molar area (in the las 30 days).
  • Surgeries taking more than 60 minutes (automatic dropout).
  • Unwillingness to participate or continue participating in the study.
  • A score equal or superior to 13 points in the Corah´s anxiety test.
  • Third molars in ectopic position.
  • Caries on the third molar.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Barcelona

L'Hospitalet de Llobregat, Catalonia, 08903, Spain

Location

Related Publications (21)

  • Berini Aytés L, Gay Escoda C, Uribarri A. Técnica de anestesia por bloqueo en la mandíbula. En: Berini Aytés L, Gay Escoda C. (eds.). Anestesia Odontológica, 3o ed. Madrid: Avances médico- dentales; 2005. p. 253-79.

    BACKGROUND
  • Meechan JG. The use of the mandibular infiltration anesthetic technique in adults. J Am Dent Assoc. 2011 Sep;142 Suppl 3:19S-24S. doi: 10.14219/jada.archive.2011.0343.

    PMID: 21881058BACKGROUND
  • Kanaa MD, Whitworth JM, Corbett IP, Meechan JG. Articaine and lidocaine mandibular buccal infiltration anesthesia: a prospective randomized double-blind cross-over study. J Endod. 2006 Apr;32(4):296-8. doi: 10.1016/j.joen.2005.09.016. Epub 2006 Feb 17.

    PMID: 16554198BACKGROUND
  • Kanaa MD, Whitworth JM, Corbett IP, Meechan JG. Articaine buccal infiltration enhances the effectiveness of lidocaine inferior alveolar nerve block. Int Endod J. 2009 Mar;42(3):238-46. doi: 10.1111/j.1365-2591.2008.01507.x.

    PMID: 19228214BACKGROUND
  • Corbett IP, Kanaa MD, Whitworth JM, Meechan JG. Articaine infiltration for anesthesia of mandibular first molars. J Endod. 2008 May;34(5):514-8. doi: 10.1016/j.joen.2008.02.042.

    PMID: 18436027BACKGROUND
  • Meechan JG. Infiltration anesthesia in the mandible. Dent Clin North Am. 2010 Oct;54(4):621-9. doi: 10.1016/j.cden.2010.06.003.

    PMID: 20831926BACKGROUND
  • Pogrel MA, Thamby S. Permanent nerve involvement resulting from inferior alveolar nerve blocks. J Am Dent Assoc. 2000 Jul;131(7):901-7. doi: 10.14219/jada.archive.2000.0308.

    PMID: 10916328BACKGROUND
  • Renton T, Adey-Viscuso D, Meechan JG, Yilmaz Z. Trigeminal nerve injuries in relation to the local anaesthesia in mandibular injections. Br Dent J. 2010 Nov;209(9):E15. doi: 10.1038/sj.bdj.2010.978.

    PMID: 21072069BACKGROUND
  • Hillerup S, Jensen R. Nerve injury caused by mandibular block analgesia. Int J Oral Maxillofac Surg. 2006 May;35(5):437-43. doi: 10.1016/j.ijom.2005.10.004. Epub 2005 Dec 15.

    PMID: 16343853BACKGROUND
  • Delgado-Molina E, Tamarit-Borras M, Berini-Aytes L, Gay-Escoda C. Comparative study of two needle models in terms of deflection during inferior alveolar nerve block. Med Oral Patol Oral Cir Bucal. 2009 Sep 1;14(9):e440-4.

    PMID: 19718006BACKGROUND
  • Hillerup S, Jensen RH, Ersboll BK. Trigeminal nerve injury associated with injection of local anesthetics: needle lesion or neurotoxicity? J Am Dent Assoc. 2011 May;142(5):531-9. doi: 10.14219/jada.archive.2011.0223.

    PMID: 21531935BACKGROUND
  • Moore PA, Haas DA. Paresthesias in dentistry. Dent Clin North Am. 2010 Oct;54(4):715-30. doi: 10.1016/j.cden.2010.06.016.

    PMID: 20831934BACKGROUND
  • Garisto GA, Gaffen AS, Lawrence HP, Tenenbaum HC, Haas DA. Occurrence of paresthesia after dental local anesthetic administration in the United States. J Am Dent Assoc. 2010 Jul;141(7):836-44. doi: 10.14219/jada.archive.2010.0281.

    PMID: 20592403BACKGROUND
  • Gaffen AS, Haas DA. Retrospective review of voluntary reports of nonsurgical paresthesia in dentistry. J Can Dent Assoc. 2009 Oct;75(8):579.

    PMID: 19840499BACKGROUND
  • Malamed SF, Gagnon S, Leblanc D. Articaine hydrochloride: a study of the safety of a new amide local anesthetic. J Am Dent Assoc. 2001 Feb;132(2):177-85. doi: 10.14219/jada.archive.2001.0152.

    PMID: 11217590BACKGROUND
  • Gay Escoda C, Berini Aytés. Técnicas anestésicas en Cirugía Bucal. En: Tratado de Cirugía Bucal. Madrid: Ergon; 2004. p. 155-98

    BACKGROUND
  • Torrente-Castells E, Gargallo-Albiol J, Rodriguez-Baeza A, Berini-Aytes L, Gay-Escoda C. Necrosis of the skin of the chin: a possible complication of inferior alveolar nerve block injection. J Am Dent Assoc. 2008 Dec;139(12):1625-30. doi: 10.14219/jada.archive.2008.0104.

    PMID: 19047668BACKGROUND
  • Brandt RG, Anderson PF, McDonald NJ, Sohn W, Peters MC. The pulpal anesthetic efficacy of articaine versus lidocaine in dentistry: a meta-analysis. J Am Dent Assoc. 2011 May;142(5):493-504. doi: 10.14219/jada.archive.2011.0219.

    PMID: 21531931BACKGROUND
  • Meechan JG, Jaber AA, Corbett IP, Whitworth JM. Buccal versus lingual articaine infiltration for mandibular tooth anaesthesia: a randomized controlled trial. Int Endod J. 2011 Jul;44(7):676-81. doi: 10.1111/j.1365-2591.2011.01878.x. Epub 2011 Mar 30.

    PMID: 21447137BACKGROUND
  • El-Kholey KE. Infiltration anesthesia for extraction of the mandibular molars. J Oral Maxillofac Surg. 2013 Oct;71(10):1658.e1-5. doi: 10.1016/j.joms.2013.06.203.

    PMID: 24040947BACKGROUND
  • Montserrat-Bosch M, Figueiredo R, Nogueira-Magalhaes P, Arnabat-Dominguez J, Valmaseda-Castellon E, Gay-Escoda C. Efficacy and complications associated with a modified inferior alveolar nerve block technique. A randomized, triple-blind clinical trial. Med Oral Patol Oral Cir Bucal. 2014 Jul 1;19(4):e391-7. doi: 10.4317/medoral.19554.

    PMID: 24608204BACKGROUND

MeSH Terms

Interventions

CarticaineEpinephrine

Intervention Hierarchy (Ancestors)

ThiophenesSulfur CompoundsOrganic ChemicalsHeterocyclic Compounds, 1-RingHeterocyclic CompoundsEthanolaminesAmino AlcoholsAlcoholsAminesBiogenic MonoaminesBiogenic AminesCatecholaminesCatecholsPhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbons

Study Officials

  • Rui Figueiredo, DDS, MS, PhD

    University of Barcelona

    STUDY DIRECTOR
  • Eduard Valmaseda-Castellon, DDS, MS. PhD

    University of Barcelona

    STUDY CHAIR
  • Stavros J Sofos, DDS, MS.

    University of Barcelona, Nova Southeastern University.

    PRINCIPAL INVESTIGATOR
  • Leonardo Berini-Aytes, MD, DDS, PhD

    University of Barcelona

    PRINCIPAL INVESTIGATOR
  • Octavi Camps-Font, DDS, MS

    University of Barcelona

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
* The participant is not told which technique will be used on him/her. * Surgeon does not know the anesthetic technique used to numb the third molar. * When the statistician and primary investigator receive the collected data to be analyzed, the techniques are labeled 1 and 2.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: * Control group: inferior alveolar nerve block with 1.8 cc of 4% articaine 1:100.000 epinephrine and 1.8 cc of the same anesthetic for the buccal nerve block. * Test group: infiltration anesthesia buccaly between first and second mandibular molar with 3.6 cc of 4% articaine 1:100.000 epinephrine and 0.6 cc ligually to the third molar using the same anesthetic.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

December 20, 2017

First Posted

February 23, 2018

Study Start

June 10, 2017

Primary Completion

November 10, 2018

Study Completion

December 20, 2018

Last Updated

March 31, 2020

Record last verified: 2020-03

Locations